We are delighted to announce that a UWE-based spin out company, Nidor Diagnostics Limited, has been established to develop a medical diagnostic device.
The device, named Inform ™, can detect the volatile organic compounds in patient samples, in order to diagnose and monitor a range of medical conditions. Founding institutional shareholders include UWE Bristol, the University of Liverpool, the University of Bristol and The Wellcome Trust.
Nidor Diagnostics Limited will offer a range of diagnostic products, the first of which would enable patients to receive a positive diagnosis of Irritable Bowel Syndrome (IBS). Currently, the diagnosis of IBS and other related medical conditions can require many assessments, including blood and faeces testing, colonoscopy with biopsies, and radiology (X-ray) tests, and requires a lengthy process of elimination. Inform (IBS) ™ will help to speed up the diagnostic process for patients.
Professor Norman Ratcliffe’s and Ben Costello’s team in the Institute of BioSensing Technology have developed the core science over many years. The team have developed extremely sensitive, low cost semiconductor based technology and pattern recognition technology for fast evaluation of urine and stool for disease diagnoses.
Dr Taj S Mattu, CEO of Nidor said: “The Universities of the West of England and Liverpool have been instrumental in developing the core technology on which Nidor is based. I am excited about realising the technology’s potential to improve the diagnosis of a number of diseases, not just IBS in the near future. Within the next six months, the company aims to raise seed investment and secure grant funding to develop its first diagnostic/prognostic test.”
Professor Martin Boddy, Pro Vice Chancellor for Research and Enterprise said “It’s good to see this big step towards getting real impact from UWE research. This research holds great potential for improving patient’s lives and also for creating jobs and spurring economic growth”.
Tracey John, Director of Research, Business and Innovation said “The formation of this spin-out company is the culmination of a wealth of research expertise to develop this ground-breaking science, in a strong collaborative partnership with University of Bristol and the University of Liverpool. It’s great to see that our intellectual property has helped secure a significant stake for UWE in Nidor Diagnostics Limited and also for the academics as founding shareholders”.
UWE IP Commercialisation team (email@example.com) can provide practical advice and support for protecting IP, such as filing
patent applications for protecting University inventions, negotiating
commercial licences, working with industry partners and setting up spin-out
more information please click here IP
& KT Guide.